Results of Bronchial Sleeve Resection for Primary Lung Cancer.
- Author:
Dae Hyun KIM
1
;
Hyo Chul YOUN
;
Soo Cheol KIM
;
Bum Shik KIM
;
Kyu Seok CHO
;
Joo Chul PARK
;
Young Tae KWAK
;
En Gu HWANG
;
Dong Won KIM
Author Information
1. Department of Thoracic and Cardiovascular Surgery, College of Medicine, Kyung Hee University, Korea. jcpark@khmc.or.kr
- Publication Type:Original Article
- Keywords:
Surgery, sleeve resection;
Lung neoplasms
- MeSH:
Adenocarcinoma;
Atrial Fibrillation;
Carcinoma, Squamous Cell;
Female;
Follow-Up Studies;
Humans;
Lung Neoplasms*;
Lung*;
Lymph Nodes;
Male;
Medical Records;
Middle Aged;
Mortality;
Neoplasm Metastasis;
Pneumonectomy;
Pneumonia;
Pulmonary Atelectasis;
Recurrence;
Retrospective Studies;
Survival Rate
- From:The Korean Journal of Thoracic and Cardiovascular Surgery
2007;40(1):37-44
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
BACKGROUND: It is known that long-term survival rate in patients underwent bronchial sleeve lobectomy for primary lung cancer is at least equal to that in patients underwent pneumonectomy, and bronchial sleeve lobectomy is performed in patients with suitable tumor location even in patients have adequate pulmonary function. Sleeve pneumonectomy is performed when carina was invaded by tumor or tumor location was near to the carina. We performed this study to know our results of sleeve resection for primary lung cancer. MATERIAL AND METHOD: We analyzed retrospectively the medical records of 45 patients who underwent sleeve lobectomy or sleeve pneumonectomy for primary lung cancer by one thoracic surgeon from May 1990 to July 2003 in Department of Thoracic & Cardiovascular Surgery, College of Medicine, Kyung Hee University. Follow-up loss was absent and last follow-up was performed in April 5, 2005. Kaplan-Meyer method and log-lank test were used to know long-term survival rate and p-value. RESULT: Mean age was 60 years old and male to female ratio 41:1. Histologic types were squamous cell carcinoma were 39, adenocarcinoma were 4, and others were 2 patients. Pathologic stages were I 14, II 14, and III 17 patients. Nodal stages were N0 23, N1 13, and N2 9 patients. Types of operation were sleeve lobectomy 40 and sleeve pneumonectomy 5 patients. Operative mortality was 3 patients and its cause was respiratory complications. Early complications were pneumonia 4, atelectasis 8, air leakage more than 7 days 6, and atrial fibrillation 4 patients. In 19 patients tumor was recurred. Local recurrence was 10 and systemic metastasis was 9 patients. Overall 5, 10-year survival rate were 54.2%, 42.5%. The 5, 10-year survival rates according to the pathologic stage were 83.9%, 67.1% in stage I, 55%, 47.1% in II, 33.3%, 25% in III, and significance difference was present between stage I and III. The 5, 10-year survival rate according to the lymph node involvement were 63.9%, 54.6% in N0, 53.8%, 46.5% in N1, 28.5%, 14.2% in N2, and significance difference was present between N0 and N2. CONCLUSION: Because bronchial sleeve lobectomy for primary lung cancer could be performed safely and shows acceptable long-term survival rate, it could be considered primary in case of suitable tumor location if complete resection is possible. Although sleeve pneumonectomy for primary lung cancer shows somewhat high operative mortality rate, it could be considered in view of curative treatment.
